Follow-The-Filings

Security · featured owners

FHTX Foghorn Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $546K

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel 0.10%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.10% Hold 111,859 $546K history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 21 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,1.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Jun 24, 2026 · 9 forms Filing Doc
4 Period Apr 9, 2026 Filing Doc
4 Period Feb 23, 2026 Filing Doc
4 Period Feb 5, 2026 Filing Doc
4 Period Jan 30, 2026 · 5 forms Filing Doc
4 Period Jan 13, 2026 Filing Doc
4 Period Nov 14, 2025 Filing Doc

Updated 2 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $34.16M $22.6M $30.91M
Net income -$98.43M -$86.62M -$74.28M
Net margin * -288.2% -383.2% -240.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $240.18M $249.6M $163.24M
Total non-current assets * $45.74M $34.38M $34.87M
Total assets $285.92M $283.98M $198.1M
Total current liabilities $58.44M $66.99M $59.74M
Total non-current liabilities * $304.67M $262.52M $246.86M
Total equity -$77.19M -$45.53M -$108.5M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$118.11M -$100.41M -$86.1M
Cash from investing $144.45M -$29.9M $112.04M
Cash from financing $1.78M $105.43M $1.02M
Net change in cash * $28.12M -$24.88M $26.96M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders